A prospective multicenter clinical trial evaluating the efficacy and safety of a hyaluronic acid‐based filler with <scp>Tri‐Hyal</scp> technology in the treatment of lips and the perioral area

Abstract

The filler demonstrated high efficacy and safety in all indications. Regional differences in longevity were evident. Thus, the necessity of regional retreatments should be discussed with patients before injection.